UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 28, 2003
SANGAMO BIOSCIENCES, INC.
(Exact name of Registrant as specified in its charter)
Delaware |
|
000-30171 |
|
68-0359556 |
|
(State or other |
|
(Commission |
|
(I.R.S. Employer |
|
|
|
|
|
|
|
501 Canal Blvd., Suite A100 |
||||
|
Richmond, California 94804 |
||||
|
(Address of principal executive offices) |
||||
|
|
||||
|
(510) 970-6000 |
||||
|
(Registrant’s telephone number, including area code) |
||||
|
ITEM 7. |
|
EXHIBITS |
||
|
|
|
|
||
|
(c) |
|
Exhibits |
||
|
|
|
99.1 |
Press Release of Sangamo BioSciences, Inc. dated October 28, 2003 reporting Sangamo BioSciences, Inc.’s financial results for the third quarter of 2003. |
|
|
|
|
|
|
|
|
ITEM 12. |
|
RESULTS OF OPERATIONS AND FINANCIAL CONDITION |
||
The information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
On October 28, 2003, Sangamo BioSciences, Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2003. A copy of the press release is attached as Exhibit 99.1.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
DATE: October 28, 2003 |
|
|
|
|
|
|
SANGAMO BIOSCIENCES, INC. |
|
|
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ EDWARD O. LANPHIER II |
|
|
|
|
Edward O. Lanphier II |
|
|
|
|
President, Chief Executive Officer |
|
2
Exhibit Index
|
|
Exhibit No. |
|
Description |
|
|
|
|
|
|
|
99.1 |
|
Press Release of Sangamo BioSciences, Inc. dated October 28, 2003 reporting Sangamo BioSciences, Inc.’s financial results for the third quarter of 2003. |
3